II. Preparations (Norgestimate / Ethinyl Estradiol)

  1. Ortho Tri-Cyclen (0.18 - 0.215 - 0.250 / 35)

III. Components

  1. Norgestimate 0.5 to 1.0 (see preparations above)
  2. Ethinyl Estradiol 35 ug

IV. Effect

  1. Relative Progestational Activity: 0.3 (low)
  2. Estrogenic Activity: 35 (moderate)
  3. Androgenic Activity: 0.15 (low)

V. Pill associated problems

  1. Indications to switch to Modicon
    1. Acne Vulgaris (lower androgen)
    2. Increased Appetite (lower Progestin)
    3. Break-through bleed days 1-9 (more Estrogen)
    4. Break-through bleed all of month (more Estrogen)
    5. Major Depression provoked (lower Progestin)
    6. Menses too light (more Estrogen, less Progestin)
  2. Indications to switch to Demulen 1/35
    1. Breast Tenderness or engorgement (lower Estrogen)
    2. Break-through bleed days 10-21 (more Progestin)
    3. Headaches (lower Estrogen)
    4. Heavy Menses (more Progestin or less Estrogen)
    5. Dysmenorrhea or Menstrual Cramps (more Progestin)
    6. Moodiness (less Estrogen or more Progestin)
    7. Weight gain (less Estrogen or more Progestin)
  3. Indications to switch to Lo/Ovral
    1. Libido decreased (more androgen)

VI. References

Images: Related links to external sites (from Bing)

Related Studies (from Trip Database) Open in New Window

Cost: Medications

ortho tri-cyclen (on 1/6/2016 at Medicaid.Gov Survey of pharmacy drug pricing)
ORTHO TRI-CYCLEN 28 TABLET Generic $0.32 each
ORTHO TRI-CYCLEN LO TABLET Generic $1.01 each

Ontology: Tri-Cyclen (C0667848)

Concepts Pharmacologic Substance (T121) , Hormone (T125) , Organic Chemical (T109)
MSH C109079
English Ortho Tri-Cyclen, triphasic oral tablet, Ortho Tri-Cyclen, Tri-Cyclen, tri-cyclen ortho, ortho tri cyclen, ortho tri-cyclen, tri cyclen, tri-cyclen, Orthotricyclen